Month: August 2020

LMS Market to Exhibit 19.1% CAGR till 2026; Implementation of BYOD to Augment Growth: Fortune Business Insights™

Written by Customer Service on August 20, 2020. Posted in Earnings Releases And Operating Results.

Pune, Aug. 20, 2020 (GLOBE NEWSWIRE) — The global LMS Market is set to be positively affected by their ability to help in exploring various methods of learning, as well as enhancing the learning process. This information is given by Fortune Business Insights™ in a published report, titled, “Learning Management System (LMS) Market Size, Share & Industry Analysis, By Component (Solution, Services), By Deployment (On-Premises, Cloud), By Organization Size (SME’s, Large Enterprises), By End User (Academic, Corporate) and Regional forecast, 2019 – 2026.” The report further states that the LMS market size stood at USD 7,206.7 million in 2018 and is projected to reach USD 29,742.0 million by 2026, exhibiting a CAGR of 19.1% in the forecast period.Click here to get the short-term and long-term impact of COVID-19 on this market.Please...

Form 8.3 – Pollen Street Secured Lending Plc

Written by Customer Service on August 20, 2020. Posted in Mergers And Acquisitions.

FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION2. POSITIONS OF THE PERSON MAKING THE DISCLOSUREIf there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)All interests and all short positions should be disclosed.Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should...

Hip Replacement Market to Reach USD 10.51 Billion by 2026 | Global Market Size, Share, Growth, Analysis, Report, Forecast [2019-2026]

Written by Customer Service on August 20, 2020. Posted in Mergers And Acquisitions.

Pune, Aug. 20, 2020 (GLOBE NEWSWIRE) — Global hip replacement market size will increase with the advent of robot-assisted surgical procedures worldwide.Fortune Business Insights in their recent report titled, “Hip Replacement Market Size, Share & Industry Analysis, By Procedure (Total Hip Replacement, Partial Hip Replacement, and Revision & Hip Resurfacing), By End User (Hospitals & Ambulatory Surgery Centers, Orthopedic Clinics, and Others) and Regional Forecast, 2019-2026”, provides a comprehensive analysis of the market and their growth trajectories.According to the report, the hip replacement market size is prognosticated to be worth USD 10.51 billion by the end of 2026 from USD 7.13 billion in 2018. The market is expected to grow at a CAGR of 5.0% within the forecast period of 2019 to 2026. As per current hip...

To Avoid Delay, the FDA Recommends CytoDyn Conduct Its Type A Meeting in Writing with FDA Response Goal Date of September 4

Written by Customer Service on August 20, 2020. Posted in Public Companies.

VANCOUVER, Washington, Aug. 20, 2020 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today it will conduct its Type A meeting in writing in lieu of a teleconference with the U.S. Food and Drug Administration (FDA). The FDA has agreed to respond to the Company’s questions by September 4, 2020 concerning the additional information the FDA requires to resubmit the Biologics License Application (BLA) for leronlimab as a combination therapy for HIV.Nader Pourhassan, Ph.D., President and Chief Executive Officer of CytoDyn, stated, “We completely understand and appreciate the FDA’s meeting schedule during these unprecedented times and are eager to discuss...

Contact Center Software Market to Exhibit 14.62% CAGR till 2026; Increasing Usage in Business Sector to Propel Growth: Fortune Business Insights™

Written by Customer Service on August 20, 2020. Posted in Mergers And Acquisitions.

Pune, Aug. 20, 2020 (GLOBE NEWSWIRE) — The global contact center software market is set to gain traction from its increasing usage in the business sector. It helps in addressing the surging importance of providing enhanced and omnichannel customer support for generating more sales. This information is given by Fortune Business Insights™ in a recent report, titled, “Contact Center Software Market Size, Share and Industry Analysis By Component (Solutions & Services), By Organization Size (Large & Small & Medium Enterprises (SMEs)), By Deployment (Cloud & On-Premises), By Vertical (Banking, Financial Services, and Insurance, IT and Telecom, Government, and others), and Regional Forecast, 2019-2026.” The report further states that the contact center software market size stood at USD 16,750.7 million in 2018 and is...

Analysis Report – Hearing Aids Market 2020 Size, Share & Growth | Global Market to Rise at 7.2% CAGR till 2026

Written by Customer Service on August 20, 2020. Posted in Mergers And Acquisitions.

Pune, Aug. 20, 2020 (GLOBE NEWSWIRE) — The hearing aids market size is projected to reach USD 14.45 billion by the end of 2026. The high prevalence of hearing disorders across the world will aid the growth of the market in the coming years.According to a report published by Fortune Business Insights, titled “Hearing Aids Market Size, Share & Industry Analysis, By Product (Hearing Devices, Hearing Implants), By Patient Type (Adult, Pediatric), By Distribution Channel (OTC (Over the Counter), Medical Channel/ Hospital Pharmacies, Private Practice/ Retail Pharmacies) and Regional Forecast, 2019-2026,” the market was worth USD 8.39 billion in 2018 and will exhibit a CAGR of 7.2% during the forecast period, 2019-2026.The other highlights of the report include:• Targeted analysis of the impact of COVID-19 on the market;• ...

Talenom vahvistaa pienasiakaskonseptin kehittämistä ostamalla Vanaja Technologies Oy:n ohjelmistoliiketoiminnan

Written by Customer Service on August 20, 2020. Posted in Public Companies.

Talenom Oyj, Lehdistötiedote 20.8.2020 kello 10:00Talenom vahvistaa pienasiakaskonseptin kehittämistä ostamalla Vanaja Technologies Oy:n ohjelmistoliiketoiminnan

Talenom acquires software business of Vanaja Technologies Oy to boost the development of the new small customer concept

Written by Customer Service on August 20, 2020. Posted in Public Companies.

Talenom Plc Press release 20 August 2020 at 10:00Talenom acquires software business of Vanaja Technologies Oy to boost the development of the new small customer conceptTalenom acquires Vanaja Technologies Oy’s software business. Talenom has developed its small customer concept together with Vanaja Technologies Oy. With the acquisition, Talenom will strengthen its software development capabilities and facilitate the long-term development of the strategic small customer concept. The business acquisition does not entail any work invoiced outside Talenom. The transaction has no impact on Talenom’s financial guidance.“I am very pleased that we will have a new R&D unit in Hämeenlinna following the acquisition of Vanaja Technologies. We were impressed by the company’s strong track record and expertise. I would like...

UPM brings its first clinical product to market – FibDex® wound dressing

Written by Customer Service on August 20, 2020. Posted in Public Companies.

(UPM, Helsinki, 20.8.2020 at 10:00 EET) FibDex® wound dressing – made from nanofibrillar cellulose by UPM Biomedicals – has taken a significant step in its path to market, as leading medical device distributor Steripolar Oy now sells the product in Finland. FibDex is the first clinical product of renowned forest-based bioindustry company UPM and shows promising signs for future developments, such as cell therapy.”We are excited to offer this Finnish product, made from Finnish raw material, first in the world to Finnish healthcare professionals and patients,” said Johana Kuncova-Kallio, Director of UPM Biomedicals. “Nanofibrillar cellulose has proven its potential both in the development of cell therapies and in clinical applications, and we are committed to further innovation.”Kaj Dahlström, CEO of Steripolar, added: “We were attracted...

UPM:n ensimmäinen kliininen tuote myyntiin – FibDex® -haavasidos terveydenhuollon ammattilaisille

Written by Customer Service on August 20, 2020. Posted in Public Companies.

(UPM, Helsinki, 20.8.2020 klo 10:00 EET) UPM Biomedicalsin nanoselluloosasta valmistaman FibDex® -haavanhoitosidoksen kaupallistaminen ottaa merkittävän askeleen, kun sairaalatarvikkeiden johtaviin tukkuliikkeisiin kuuluva Steripolar Oy alkaa myydä FibDexiä Suomessa. FibDex on ensimmäinen UPM:n kliininen tuote, jonka jatkokehitysmahdollisuudet muun muassa soluterapiassa ovat lupaavia.”Olemme innoissamme, kun voimme tarjota suomalaisille terveydenhoidon ammattilaisille ja potilaille suomalaisesta raaka-aineesta Suomessa valmistetun tuotteen. Nanoselluloosa on osoittanut vahvuutensa soluhoitojen kehityksessä ja kliinisissä sovelluksissa, joiden kehittämiseen panostamme määrätietoisesti”, sanoo UPM Biomedicalsin johtaja Johana Kuncova-Kallio.”FibDexissä kiinnostavaa on sen innovatiivisuus. Olemme aina yrittäneet olla nälkäisiä tuotteiden ja...

Month: August 2020

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals